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which are central to eliminate viral and bacterial infection. However, uncontrolled TLR4 activation
may contribute to pathogenesis of inﬂammatory diseases such as septic shock. In this study, we
found microRNA-210 was induced in murine macrophages by LPS. Transfection of miR-210 mimics
signiﬁcantly inhibited LPS-induced production of inﬂammatory cytokines. In contrast, transfection
of anti-miR-210 inhibitors increased LPS-induced expression of proinﬂammatory cytokines. Fur-
thermore, we demonstrated that miR-210 targets NF-jB1. Therefore, our data identify miR-210 as
a very important feedback negative regulator for LPS-induced production of proinﬂammatory
cytokines.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Toll-like receptors (TLRs) play a critical role in innate immunity
[1]. Recognition of PAMPs by TLRs initiates signaling cascades
composed of various adaptor molecules and ﬁnally leads to the
activation of NF-jB and MAP kinase pathways and the induction
of proinﬂammatory cytokines [2]. The most common ligand for
TLR4 is lipopolysaccharide (LPS), a cell wall component of gram-
negative bacteria [3]. Uncontrolled TLR4 activation by LPS and
production of proinﬂammatory cytokines such as TNF-a, IL-1b
and IL-6 are the main cause of septic shock. Therefore, studies on
the mechanisms of negative regulation of LPS-induced inﬂamma-
tory responses are essential for the cure of septic shock [4].
microRNAs (miRNAs) are highly conversed, small non-coding
RNA molecules that play an essential role in the regulation of gene
expression. Mature miRNA interacts with a speciﬁc mRNA through
pairing of nucleotide bases between the miRNA sequence and the
30 untranslated region (30UTR) of speciﬁc mRNA, and leads to trans-
lational repression or degradation of target mRNA [5]. Emergingchemical Societies. Published by E
lysaccharide; NF-jB, nuclear
ion
of Immunology, Shandong
n, Shandong 250012, China.evidences have shown that microRNAs play an important role in
both adaptive and innate immunity [6–8]. For example, ectopic
expression of miR-181a in hematopoietic stem/progenitor cells
modulates the differentiation of T and B cell [9,10]. miR-146, which
was induced by LPS in human monocytes, acts as a feedback neg-
ative regulator for TLR-induced inﬂammatory responses through
targeting IRAK-1 and TRAF6 [11]. miR-147, another microRNA
induced by TLRs stimulation in murine macrophages, functions
as a negative regulator of TLR-induced inﬂammatory response,
although the molecular target was not identiﬁed [12]. Similar to
miR-146 and 147, miR-155 is also induced during the macrophage
inﬂammatory responses and targets Src homology-2 domain-con-
taining inositol 5-phosphatase 1 (SHIP1) to regulate the kinase
Akt activation upon LPS stimulation [13,14].
In this study, we demonstrate that miR-210, a LPS-induced
microRNA in murine macrophages, works as a negative regulator
for LPS-induced expression of proinﬂammatory cytokines. Further-
more, we demonstrate that miR-210 targets NF-jB1 to decrease
NF-jB activation.
2. Materials and methods
2.1. Mice and reagent
C57BL/6J mice were obtained from Joint Ventures Sipper BK
Experimental Animal (Shanghai, China). All animal experimentslsevier B.V. All rights reserved.
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Health Guide for the Care and Use of Laboratory Animals, with
the approval of the Scientiﬁc Investigation Board of Medical School
of Shandong University, Jinan, China. LPS (Escherichia coli, 055:B5)
was purchased from Sigma (St. Louis, MO). Antibodies for p50,
STAT1, b-actin and their respective horseradish peroxidase-
conjugated secondary antibodies were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA).
2.2. Plasmid constructs
All 30UTR reporter vectors were prepared by ampliﬁcation of the
full-length 30UTR of the corresponding gene, followed by insertion
into the pGL3-promoter vector (Promega). Information of the
primers used for the construction of reporters is upon request.
NF-jB-luc reporter plasmid was purchased from Stratagene.
Expression plasmids for TRAF6, TAK1 and IKK-b were from Dr.
Hui Xiao (Institut Pasteur of Shanghai, CAS, China). MyD88 and
TAB1 expression plasmids were kind gifts from Dr. Xuetao Cao
(Second Military Medical University, China) and Dr. Danying Chen
(Peking University, China), respectively.
2.3. Cell culture
Thioglycolate-elicited primary mouse peritoneal macrophages
were prepared as described [15]. Mouse macrophage cell line
RAW264.7 and human HEK293 cells were obtained from the
American Type Culture Collection (Manassas, VA). The cells were
cultured at 37 C under 5% CO2 in DMEM supplemented with 10%
FCS (Invitrogen-Gibco), 100 U/ml penicillin, and 100 lg/ml strepto-
mycin. LPS were used at a ﬁnal concentration of 100 ng/ml.
2.4. Transfection
miR-210 mimics, scrambled control microRNA, anti-miR-210
inhibitor and anti-microRNA control inhibitor were obtained from
Genepharma (Shanghai, China). The miRNA-210 sequence was 50-
CUGUGCGUGUGACAGCGGCUGA-30. The scrambled control miRNA
sequence was 50-UUCUCCGAACGUGUCACGU-30. The anti-microR-
NA control sequence is 50-CAGUACUUUUGUGUAGUACAA-30. The
anti-miR-210 inhibitor sequence is 50-UCAGCCGCUGUCACACGCA-
CAG-30. HIF1-a siRNA and control scrambled siRNA were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA). For
1  106 cells, 0.4 nmol microRNA mimics or anti-microRNA inhibi-
tors was mixed with 15 ll Geneporter 2 Transfection Reagent (GTS,
San Diego) and transfected into the cells. After 6 h, the supernatant
was removed and fresh medium was added. The cells were cul-
tured for another 48 h before further experiments.
2.5. microRNA arrays
Total RNA was harvested from macrophages using TRIZOL
(Invitrogen) and RNeasy mini kit (Qiagene) according to manufac-
turer’s instructions. After having passed RNA measurement on the
Nanodrop instrument, the samples are labeled using the miRCU-
RY™ Hy3™/Hy5™ Power labeling kit and hybridized on the miR-
CURY™ LNA Array (v.11.0). The samples were hybridized, and
scanning is performed with the Axon GenePix 4000B microarray
scanner. GenePix pro V6.0 is used to read the raw intensity of
the image.
2.6. RNA quantitation and immunoblot analysis
Total RNA was extracted with TRIzol reagent according to the
manufacturer’s instructions (Invitrogen). For microRNA quantiﬁca-
tion, the complementary DNA synthesis was performed using theReverse Transcription Kit (Epicentre) with RT-U6 and miRNA-spe-
ciﬁc stem-loop primers (1 lM). For other mRNA quantiﬁcation, the
complementary DNA synthesis was performed with Oligo(dT). A
LightCycler (ABI PRISM 7000) and a SYBR RT-PCR kit (Takara)
were used for quantitative PCR analysis. Information of the primers
used in PCR analysis is upon request. For immunoblot analysis,
cells were lysed with M-PER Protein Extraction Reagent (Pierce,
Rockford, IL) supplemented with a protease inhibitor ‘cocktail’,
then protein concentrations in the extracts were measured with
a bicinchoninic acid assay (Pierce, Rockford, IL). Equal amounts of
extracts were separated by SDS–PAGE, and transferred onto nitro-
cellulose membranes for immunoblot analysis as described previ-
ously [15].
2.7. Detection of cytokines production
2  105 mouse peritoneal macrophages were seeded into 24-
well plates and incubated overnight. Cells were stimulated with
LPS. The concentrations of TNF-a and IL-6 in culture supernatants
were measured by ELISA Kits (R&D Systems, Minneapolis, MN).
2.8. Assay of luciferase reporter gene expression
HEK293 cells were cotransfected with a mixture of indicated
luciferase reporter and indicated amounts of MyD88, TRAF6,
TAK1 plus TAB1, or IKK-b construct. Luciferase activities were mea-
sured with Dual-Luciferase Reporter Assay System (Promega)
according to the manufacturer’s instructions. Data are normalized
for transfection efﬁciency by dividing Fireﬂy luciferase activity
with that of Renilla luciferase.
2.9. Statistical analysis
All data are presented as means ± S.E. of three or four experi-
ments. Analysis was performed using a Student’s t test. Values of
P < 0.05 were considered signiﬁcant.
3. Results
3.1. LPS-induced expression of miR-210 in murine macrophages
To identify microRNAs induced by LPS in murine macrophages,
primary peritoneal macrophages were stimulated with LPS for 24 h
and a microRNA array was performed (analyzed by Exiqon). The
expression of iNOS, TNF-a and IL-12p40 were remarkably up-regu-
lated 24 h after LPS stimulation as measured by semi-quantitative
PCR (Fig. 1A), indicating LPS effectively activated these murine
macrophages. Then, a microRNA array was performed and revealed
that the expression of several miRNAs was either up-regulated or
down-regulated upon LPS challenge (Fig. 1B). Among the up-
regulated microRNAs, miR-155, miR-147, miR-146 were induced
344, 18 and 4-fold, respectively, which have been previously
shown to be induced in LPS stimulated macrophages [11–13].
Other LPS-induced microRNAs included miR-210 and miR-125a,
which were induced 6 and 5-fold, respectively. In this report,
miR-210 was chosen for further studies. To validate the data ob-
tained by microRNA array analysis, quantitative real-time PCR
was performed. As shown in Fig. 1C, mature miR-210 was up-reg-
ulated about 8-fold after LPS stimulation for 24 h (P < 0.05). Fur-
thermore, LPS stimulation could induce miR-210 expression in a
dose-dependent manner (Fig. 1D). LPS-TLR4 pathway has been
shown to induce the expression of HIF1-a, a crucial activator of
mIR-210 upon hypoxia. In order to investigate whether HIF1-a
was involved in LPS-induced miR-210 expression, HIF1-a siRNA
was transfected into primary macrophages to knockdown the
expression of HIF1-a. As shown in Fig. 1E, transfection of HIF1-a
Fig. 1. LPS-induced expression of miR-210 in murine macrophages. (A) Mouse peritoneal macrophages were treated with 100 ng/ml LPS for 24 h. Expression level of iNOS,
TNF-a and IL-12p40 mRNA was examined by semi-quantitative PCR. b-actin serves as a loading control. (B) Microarray analysis of miRNA expression in macrophages treated
with LPS for 24 h. Each dot represents one miRNA probe in the scatter plot.r: miR-155,s: miR-147,t: miR-125a-5p,u: miR-146,v: miR-210. (C) miR-210 expression was
determined by quantitative real-time PCR and normalized with U6 RNA. (D) Mouse peritoneal macrophages were treated with different concentration of LPS 24 h, and miR-
210 expression was determined by quantitative real-time PCR and normalized with U6 RNA. E: Mouse peritoneal macrophages were transfected with HIF1-a siRNA or control
siRNA, after 48 h, the cells were treated with 100 ng/ml LPS for 24 h, and the expression of miR-210 and HIF1-a were determined by quantitative real-time PCR. Data are
shown as mean ± S.E. (n = 3) of one representative experiment. (⁄P < 0.05).
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siRNA transfection, indicating HIF1-a is involved in the regulation
of miR-210 expression in macrophages. Taken together, these data
indicate that LPS stimulation lead to the increased expression of
several miRNAs including miR-210.
3.2. miR-210 inhibits expression of proinﬂammatory cytokines
LPS-induced expression of miR-210 indicates miR-210 may
have a regulatory role in LPS/TLR4 signaling. To investigate the
possible functions of miR-210 in LPS/TLR4 signaling, miR-210
mimics were transfected into peritoneal primary macrophages,
secretion of proinﬂammatory cytokines including IL-6 and TNF-a
was measured by ELISA after LPS stimulation. Expression of miR-
210 was validated by quantitative real-time PCR after transfection
of miR-210 mimics (Fig. 2A). Compared to control microRNA mim-
ics transfected macrophages, LPS-induced secretion of IL-6 and
TNF-a was signiﬁcantly decreased in miR-210 mimics transfected
macrophages (Fig. 2B, P < 0.05). Similarly, the expression level of
steady state mRNA of IL-6, TNF-a and iNOS was also greatly atten-
uated by miR-210 mimics transfection, compared to control micr-
oRNA mimics transfection (Fig. 2C, P < 0.05). To further conﬁrm the
function of miR-210 in LPS-induced production of proinﬂamma-
tory cytokines, anti-miRNA inhibitors were transfected into macro-
phages. Transfection of anti-mi-210 inhibitors greatly attenuated
miR-210 expression in macrophages compared to control anti-
miRNA inhibitors (Fig. 2D). As shown in Fig. 2E, inhibition of
miR-210 expression increased LPS-induced IL-6 and TNF-a secre-
tion. At the same time, the expression level of steady state mRNAfor IL-6, TNF-a and iNOS was also greatly increased with the trans-
fection of miR-210 inhibitors (Fig. 2F). All together, these data sug-
gest that miR-210 negatively regulates LPS-induced expression of
proinﬂammatory cytokines.
3.3. miR-210 targets molecules downstream of IKK-b
Production of proinﬂammatory cytokines upon LPS stimulation
in macrophages depends mainly on the activation of transcription
factors NF-jB through the adaptors MyD88 and TRIF. Recruitment
of MyD88 and TRIF promotes the interaction and phosphorylation
of IRAKs and subsequent activation of TRAF6 and TAK1, leading to
the activation of NF-jB and the induction of proinﬂammatory
cytokines (2). To determine the function of miR-210 on the NF-
jB activation and the molecular order of miR-210 in the LPS-in-
duced NF-jB activation, NF-jB-luc reporter plasmid and various
signaling molecules in the LPS/TLR4 signaling pathway were trans-
fected into HEK293 cells together with miR-210 mimics. As shown
in Fig. 3, MyD88, TRAF6, TAK1 plus TAB1, and IKK-b induced NF-jB
luciferase activity was greatly inhibited by miR-210 mimics trans-
fection, compared to that of control microRNA mimics transfection
(P < 0.05). These data indicate that miR-210 targets molecules
downstream of IKK-b to inhibit NF-jB activation and subsequent
production of proinﬂammatory cytokines.
3.4. miR-210 targets NF-jB1
To identify the potential miR-210 targets in the LPS/TLR4 sig-
naling, the microRNA prediction programs including miRWalk,
Fig. 2. miR-210 inhibits TLR4-induced proinﬂammatory cytokines expression. (A–C) Peritoneal macrophages were transfected with control microRNA mimics or miRNA-210
mimics and then stimulated with 100 ng/ml LPS for 6 h. miR-210 expression was measured by quantitative real-time PCR after transfection of miR-210 mimics or microRNA
control (A). Secretion of IL-6 and TNF-a in the cell culture supernatants was determined by ELISA (B). Expression level of IL-6, TNF-a and iNOS mRNA was examined by
quantitative real-time PCR (C). (D–F): Peritoneal macrophages were transfected with anti-miR-210 inhibitor or anti-microRNA control and then stimulated with 100 ng/ml
LPS for 6 h. miR-210 expression was measured by quantitative real-time PCR after transfection of miR-210 mimics or microRNA control (D). Secretion of IL-6 and TNF-a in the
cell culture supernatants was determined by ELISA (E). Expression level of IL-6, TNF-a and iNOS mRNA was examined by quantitative real-time PCR (F). The data are shown as
mean ± S.E. of triplicate samples. (⁄P < 0.05).
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binding site was predicted in the 30UTR region of NF-jB1 withthese four programs (Fig. 4A). To directly conﬁrm miR-210 targets
NF-jB1 through 30UTR, the 30UTR of p105 was cloned and fused
Fig. 3. miR-210 targets molecules downstream of IKK-b. (A–D): HEK293 cells were transfected with MyD88, TRAF6, TAK1 plus TAB1, or IKK-b, along with NF-jB reporter
plasmid, TK-Renilla plasmid and miRNA-210 mimic or control mimic for 24 h. Luciferase activity was measured and normalized by Renilla luciferase activity. Data are shown
as mean ± S.E. (n = 6) of one representative experiment. (⁄P < 0.05).
Fig. 4. miR-210 targets NF-jB1. (A): Conserved miR-210-binding sites (underlined) in the 30UTR of p105 mRNA and pGL3-promoter luciferase plasmids used for miRNA
reporter assays. WT: wild type; MU1: point mutation; MU2: deletion mutation; mmu: Mus musculus. (B and C): HEK293 cells were transfected with p50–30UTR-WT, p50–
30UTR-MU1, p50–30UTR-MU2 or IL-6–30UTR reporter plasmids and TK-Renilla plasmid, along with the miRNA-210 mimic or control mimic for 24 h. Luciferase activity was
measured and normalized by Renilla luciferase activity. Data are shown as mean ± S.E. (n = 6) of one representative experiment. (⁄P < 0.05, NP > 0.05) (D and E): Peritoneal
macrophages were transfected with miRNA-210 mimic or control mimic and anti-miR-210 inhibitor or control anti-microRNA inhibitor, respectively. After 48 h. p50, STAT1
and b-actin in lysates were detected by immunoblot. Bar graphs show the fold change of each protein relative to the level in control mimic transfected cells by densitometry.
Similar results were obtained in three independent experiments.
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construct (p50–30UTR-WT). At the same time, two mutant lucifer-
ase reporters were constructed with the miR-210 binding site
either mutated (p50–30UTR-MU1) or deleted (p50–30UTR-MU2),
respectively (Fig. 4A). These luciferase reporters were transientlytransfected into HEK293 cells together with miR-210 mimics.
Transfection of miR-210 mimics signiﬁcantly inhibited the lucifer-
ase activity of the report construct with the wild type 30UTR of
p105 in a dose-dependent manner (Fig. 4B, P < 0.05). But, the inhib-
itory effect of miR-210 on the luciferase activity was abrogated
1206 J. Qi et al. / FEBS Letters 586 (2012) 1201–1207after the miR-210 binding site in the 30UTR of p105 was mutated
(Fig. 4C, P > 0.05). As a control, transfection of miR-210 mimics
could not inhibit the luciferase activity of the reporter construct
with the 30UTR of IL-6 (Fig. 4C, P > 0.05).
To further conﬁrm miR-210 inhibits p105 expression in physio-
logical conditions, control microRNA mimics or miR-210 mimics
were transfected into peritoneal primary macrophages, the expres-
sion level of p105 and p50 was measured by western blotting anal-
ysis. As shown in Fig. 4D, the expression of endogenous p105 and
p50 was greatly decreased with transfection of miR-210 mimics,
compared to that of control microRNA mimics transfection. In con-
trast, the expression level of transcription factor STAT1 could not
be changed by miR-210 mimics transfection. In accordance with
the inhibitory effect of miR-210 on NF-jB1 expression, transfec-
tion of miR-210 inhibitors substantially increased the protein
expression of p105 and p50 in primary macrophages, compared
to transfection of control miRNA inhibitors (Fig. 4E). All together,
these data suggest that NF-jB1 is direct target for miR-210.
4. Discussion
microRNAs (miRNAs) are highly conversed, small non-coding
RNA molecules and play a very important role in the regulation
of gene expression [5]. Accumulating data showed that microRNAs
play a pivotal role in innate immunity [8]. In macrophages or
monocytes, several microRNAs are up-regulated upon TLR4 activa-
tion by LPS and have been demonstrated to negatively regulate
NF-jB activation and subsequent production of proinﬂammatory
cytokines. Therefore, they represent a special family of negative
regulators to restrict LPS-induced excessive proinﬂammatory re-
sponses. In this study, we have provided evidence to show that
miR-210 is associated with TLR4 activation by LPS. Importantly,
we demonstrated that LPS-induced miR-210 functions as negative
regulator in LPS-induced expression of proinﬂammatory cytokines
by targeting NF-jB1 in murine macrophages. Thus, miR-210 joins
miR-146 and miR-147 et al. as a new feedback negative regulator
in the LPS/TLR4 signaling pathway.
NF-jB1 (also known as p105) is a key member of the transcrip-
tional regulator family called nuclear factor jB (NF-jB). p105 can
be processed into the mature p50 proteins that form heterodimers
with p65 (also known as RelA). p65/p50 are the most abundant
form of NF-jB that positively regulate the expression of NF-jB tar-
get genes [16]. Therefore, targeting NF-jB1 represent a novel strat-
egy to modulate the expression of NF-jB regulated genes. In this
regard, miR-9 has been shown to target and inhibit the expression
of NF-jB1 [17]. miR-9 is up-regulated in human polymorphonu-
clear neutrophils (PMN) and monocytes upon TRL4 activation by
LPS in a NF-jB-dependent manner. So the authors propose that
LPS-induced expression of miR-9 operates as a feedback regulator
for the NF-jB-dependent responses by ﬁne tuning the expression
of NF-jB1 [17]. In this study, we demonstrated that transfection
of miR-210 mimics signiﬁcantly attenuated the activation of the
luciferase reporter with NF-jB1 30UTR. Importantly, transfection
of miR-210 mimics into macrophages signiﬁcantly inhibited
p105/p50 protein expression. In contrast, transfection of anti-
miR-210 inhibitors into macrophages substantially increased
p105/p50 protein expression. Therefore, our data identify
miR-210 as another microRNA to inhibit the expression of NF-
jB1.miR-210 has been extensively studied in hypoxia related dis-
eases such as tumor, inﬂammation and ischemia and was named
as ‘‘a unique and pleiotropic hypoxamir’’ [18]. Fasanaro et al. found
that the expression of miR-210 increased progressively upon expo-
sure to hypoxia and affect cell survival, migration, and differentia-
tion through interacting with Ephrin-A3 [19]. miR-210 was also
found to target the Iron-Sulfur Cluster Assembly Proteins ISCU1/2
to control mitochondrial metabolism during hypoxia [20]. miR-210 was demonstrated to attenuate keratinocyte proliferation and
impairs closure in a murine model of ischemic wounds [21]. miR-
210 can also inhibit cancer cell survival and proliferation by induc-
ing cell death and cell cycle arrest in G(1)/G(0) and G(2)/M through
targeting ﬁbroblast growth factor receptor-like 1 (FGFRL1) [22]. In
the present study, we demonstrated that miR-210 can attenuate
LPS-induced inﬂammatory responses by targeting NF-jB1, indicat-
ing miR-210 is also a very important regulator in the immune
responses.
In conclusion, our results demonstrate LPS-induced expression
of miR-210 negatively regulates LPS-induced production of proin-
ﬂammatory cytokines. Furthermore, we demonstrate that miR-
210 targets NF-jB1 to inhibit the expression of p50 and subse-
quent NF-jB activation. Therefore, the present study identiﬁed a
new feedback negative player in the LPS/TLR4 signaling and re-
vealed a new function for miR-210.
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